The FDA recently approved a new non-steroidal anti-inflammatory drug (NSAID) that can be applied to the skin over a horse's joint to relieve pain of osteoarthritis. The approval represents the first topical equine pharmaceutical formulation of a compound called diclofenac that uses liposome technology--which allows medication to be absorbed straight to the site of the horse’s joint
To continue reading this article, become a member of TheHorse.com.
It's FREE and you'll get full access to more than 20,000 articles, video, free reports & more.
